ZWJ Investment Counsel Inc. Has $269,000 Stock Position in Colgate-Palmolive Company $CL

ZWJ Investment Counsel Inc. decreased its position in shares of Colgate-Palmolive Company (NYSE:CLFree Report) by 11.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,961 shares of the company’s stock after selling 400 shares during the period. ZWJ Investment Counsel Inc.’s holdings in Colgate-Palmolive were worth $269,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Brighton Jones LLC lifted its position in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares during the last quarter. Foster Group Inc. increased its stake in Colgate-Palmolive by 20.5% during the first quarter. Foster Group Inc. now owns 3,392 shares of the company’s stock valued at $318,000 after acquiring an additional 577 shares during the period. Curat Global LLC bought a new position in Colgate-Palmolive during the first quarter valued at about $131,000. Procyon Advisors LLC increased its stake in Colgate-Palmolive by 225.9% during the first quarter. Procyon Advisors LLC now owns 13,566 shares of the company’s stock valued at $1,271,000 after acquiring an additional 9,403 shares during the period. Finally, Horizon Wealth Management LLC grew its stake in shares of Colgate-Palmolive by 3.1% in the 1st quarter. Horizon Wealth Management LLC now owns 4,633 shares of the company’s stock valued at $434,000 after purchasing an additional 139 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on CL. Piper Sandler assumed coverage on Colgate-Palmolive in a research note on Friday. They issued a “neutral” rating and a $84.00 price objective on the stock. Barclays reduced their price objective on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a report on Wednesday. UBS Group reduced their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. The Goldman Sachs Group cut their price target on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday. Finally, JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $94.83.

Check Out Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Price Performance

CL stock opened at $78.01 on Friday. The stock has a 50-day moving average price of $83.29 and a two-hundred day moving average price of $88.32. Colgate-Palmolive Company has a 1 year low of $77.91 and a 1 year high of $102.61. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock has a market cap of $63.05 billion, a PE ratio of 21.91, a price-to-earnings-growth ratio of 4.06 and a beta of 0.34.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the prior year, the business posted $0.91 EPS. The company’s quarterly revenue was up 1.0% on a year-over-year basis. Equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.43%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.